Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma

Journal of Clinical Oncology

Volumn 27, Issue 2, 2009, Pages 271-278

  Anagnostou, Valsamo K ^a   Syrigos, Konstantinos N ^a   Bepler, Gerold ^a   Homer, Robert J ^a   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID TRANSCRIPTION FACTOR 1; NUCLEAR PROTEIN; THYROID NUCLEAR FACTOR 1; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; ADENOCARCINOMA; BIOSYNTHESIS; COHORT ANALYSIS; LUNG TUMOR; METABOLISM; MULTIVARIATE ANALYSIS; PATHOLOGY;

ADENOCARCINOMA; AGED; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 58249091530     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.17.0043     Document Type: Article

References (32)

1. Guazzi S, Price M, De Felice M, et al: Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 9:3631-3639, 1990
2. Kimura S, Hara Y, Pineau T, et al: The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10:60-69, 1996
3. Bruno MD, Bohinski RJ, Huelsman KM, et al: Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J Biol Chem 270:6531-6536, 1995
4. Yan C, Sever Z, Whitsett JA: Upstream enhancer activity in the human surfactant protein B gene is mediated by thyroid transcription factor 1. J Biol Chem 270:24852-24857, 1995
5. Kelly SE, Bachurski CJ, Burhans MS, et al: Transcription of the lung-specific surfactant protein C gene is mediated by thyroid transcription factor 1. J Biol Chem 271:6881-6888, 1996
6. Zhang L, Whitsett JA, Stripp BR: Regulation of Clara cell secretory protein gene transcription by thyroid transcription factor-1. Biochim Biophys Acta 1350:359-367, 1997
7. Yatabe Y, Mitsudomi T, Takahashi T: TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol 26:767-773, 2002
8. Garraway LA, Sellers WR: Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 6:593-602, 2006
9. Tanaka H, Yanagisawa K, Shinjo K, et al: Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res 67:6007-6011, 2007
10. Travis WD, Sobin LH: Histological Typing of Lung and Pleural Tumours (ed 3). Berlin, Germany, Springer-Verlag, 1999
11. Sheppard MN: Specific markers for pulmonary tumours. Histopathology 36:273-276, 2000
12. Ordóñez NG: Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol 24:598-606, 2000
13. Stenhouse G, Fyfe N, King G, et al: Thyroid transcription factor 1 in pulmonary adenocarcinoma. J Clin Pathol 57:383-387, 2004
14. Kaufmann O, Dietel M: Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology 36:8-16, 2000
15. Di Loreto C, Di Lauro V, Puglisi F, et al: Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol 50:30-32, 1997
16. Berghmans T, Paesmans M, Mascaux C, et al: Thyroid transcription factor 1: A new prognostic factor in lung cancer - A meta-analysis. Ann Oncol 17:1673-1676, 2006
17. Barlési F, Pinot D, Legoffic A, et al: Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung. Br J Cancer 93:450-452, 2005
18. Myong NH: Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: Its prognostic implication and relationship with expressions of p53 and Ki-67 proteins. J Korean Med Sci 18:494-500, 2003
19. Tan D, Li Q, Deeb G, et al: Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: A high-throughput tissue microarray and immunohistochemistry study. Hum Pathol 34:597-604, 2003
20. Saad RS, Liu YL, Han H, et al: Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Hum Pathol 35:3-7, 2004
21. McCabe A, Dolled-Filhart M, Camp RL, et al: Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. J Natl Cancer Inst 97:1808-1815, 2005
22. Camp RL, Chung GG, Rimm DL: Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 8:1323-1327, 2002
23. Hoffman PC, Mauer AM, Vokes EE: Lung cancer. Lancet 355:479-485, 2000
24. Hotta K, Matsuo K, Ueoka H, et al: Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 22:3860-3867, 2004
25. Arriagada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004
26. Thomas P, Doddoli C, Thirion X, et al: Stage I non-small cell lung cancer: A pragmatic approach to prognosis after complete resection. Ann Thorac Surg 73:1065-1070, 2002
27. Macchiarini P, Fontanini G, Hardin MJ, et al: Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340:145-146, 1992
28. Haque AK, Syed S, Lele SM, et al: Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: Strong thyroid transcription factor-1 expression predicts better survival. Appl Immunohistochem Mol Morphol 10:103-109, 2002
29. Puglisi F, Barbone F, Damante G, et al: Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Mod Pathol 12:318-324, 1999
30. Pelosi G, Fraggetta F, Pasini F, et al: Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol 25:363-372, 2001
31. Au NH, Cheang M, Huntsman DG, et al: Evaluation of immunohistochemical markers in nonsmall cell lung cancer by unsupervised hierarchical clustering analysis: A tissue microarray study of 284 cases and 18 markers. J Pathol 204:101-109, 2004
32. Shah L, Walter KL, Borczuk AC, et al: Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with non-small cell lung carcinoma. Cancer 101:1632-1638, 2004